European Medicines Agencies Network Strategy to 2025

On 8 December 2020 the EMA Published the Joint Strategy Setting Direction for EMA and EU Medicines Regulatory Agencies to 2025.

EMA and the Heads of Medicines Agencies (HMA) have published their joint strategy for the next five years, following its recent adoption by the HMA and EMA Management Board.

The strategy details how the European medicines regulatory network can continue to enable the supply of safe and effective medicines that meet patients’ needs in the face of challenges posed by ever-accelerating developments in science, medicine, digital technologies, globalization as well as emerging health threats, such as the COVID-19 pandemic.

Read the pdf 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /